US Patent Issued to Regeneron Pharmaceuticals on April 15 for "Compositions and methods for treating cytokine release syndrome" (New York Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,274,747, issued on April 15, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).

"Compositions and methods for treating cytokine release syndrome" was invented by Kara Olson (White Plains, N.Y.), Olga Sineshchekova (Pleasantville, N.Y.), Eric Smith (New York) and Chia-Yang Lin (Scarsdale, N.Y.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compositions and methods for treating cancer and inhibiting cytokine release syndrome (CRS). The methods of the present invention comprise administering to a subject in need thereof a therapeutically effective amount of a CD40 antagonist or a CAR-T cell expressing a CD40 ant...